Bionano Genomics Inc
(BNGO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,124 | -132,596 | -93,919 | -62,112 | -29,952 |
| Depreciation Amortization | 3,159 | 10,478 | 7,718 | 5,143 | 2,538 |
| Income taxes - deferred | N/A | 1,760 | N/A | N/A | N/A |
| Accounts receivable | 242 | -2,251 | -1,134 | 24 | -640 |
| Accounts payable and accrued liabilities | 3,017 | 1,949 | -1,233 | -2,073 | -3,168 |
| Other Working Capital | -3,327 | -27,939 | -21,860 | -15,435 | -10,560 |
| Other Operating Activity | 1,620 | 23,783 | 20,129 | 13,627 | 9,288 |
| Operating Cash Flow | $-32,413 | $-124,816 | $-90,299 | $-60,826 | $-32,494 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -360 | -2,382 | -1,029 | -344 | -123 |
| Net Acquisitions | N/A | -30,650 | 694 | 694 | 694 |
| Purchase Of Investment | N/A | -84,195 | -63,208 | -29,541 | -14,954 |
| Sale Of Investment | 16,888 | 200,888 | 135,386 | 93,475 | 47,179 |
| Purchase Sale Intangibles | N/A | -102 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -894 | -686 | -1,080 | -832 |
| Investing Cash Flow | $16,528 | $82,767 | $71,157 | $63,204 | $31,964 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -10 | -36 | -26 | -17 | -8 |
| Common Stock Issued | 15,252 | 23,621 | 23,465 | 227 | 15 |
| Other Financing Activity | -380 | -578 | -578 | 0 | 0 |
| Financing Cash Flow | $14,862 | $23,007 | $22,861 | $210 | $7 |
| Exchange Rate Effect | 36 | -38 | -124 | N/A | N/A |
| Beginning Cash Position | 5,491 | 24,571 | 24,571 | 24,571 | 24,571 |
| End Cash Position | 4,504 | 5,491 | 28,166 | 27,159 | 24,048 |
| Net Cash Flow | $-987 | $-19,080 | $3,595 | $2,588 | $-523 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,413 | -124,816 | -90,299 | -60,826 | -32,494 |
| Capital Expenditure | -360 | -2,408 | -1,055 | -371 | -150 |
| Free Cash Flow | -32,773 | -127,224 | -91,354 | -61,197 | -32,644 |